openPR Logo
Press release

Orexin Receptor Market 2024 Analysis, Share, Trends, and Overview 2024-2031

12-06-2024 03:34 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Orexin Receptor Market

Orexin Receptor Market

The global orexin receptor market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Orexins are also known as hypocretins. They are two neuropeptides secreted from orexin-containing neurons, mainly in the lateral hypothalamus (LH). They play a vital regulatory role in many physiological processes such as feeding behavior, sleep-wake rhythm, reward and addiction and energy balance. The major factor driving the growth of the market is the rising prevalence of depressive disorder across the globe.

Get Free Sample link @ https://www.omrglobal.com/request-sample/orexin-receptor-market

According to the National Institute of Mental Health (NHIM), in 2019, an estimated 19.4 million adults in the US had at least one major depressive episode which represented 7.8% of adults. Furthermore, according to World Health Organization (WHO), depression is a leading cause of disability globally with an estimated 3.8% of the population affected, including 5.0% among adults and 5.7% among adults older than 60 years in 2021. Hence, the increasing prevalence of the depressive disorder is driving the demand for orexin receptors owing to their application as an anti-depressant which in turn is driving the growth of the market.

Some major players in the market include Merck & Co. Inc., GlaxoSmithKline plc, and Eisai Co., Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2020, Eisai Co., Ltd. announced the launch of its in-house-discovered and developed orexin receptor antagonist DAYVIGO 2.5 mg, 5 mg, 10 mg tablets (lemborexant) in Japan. It is used for the treatment of insomnia.

Full report of Orexin Receptor Market available @ https://www.omrglobal.com/industry-reports/orexin-receptor-market

Market Coverage

Segment Covered-
o By Type

o By Application

Regions Covered-
o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- Merck & Co. Inc., GlaxoSmithKline plc, and Eisai Co., Ltd., among others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Orexin Receptor Market Report by Segment

By Type

Orexin 1 Receptor
Orexin 2 Receptor

By Application

Insomnia
Sleep Disorders
Major Depressive Disorder
Other

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/orexin-receptor-market

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Orexin Receptor Market 2024 Analysis, Share, Trends, and Overview 2024-2031 here

News-ID: 3776704 • Views:

More Releases from Orion Market Research

Augmented Reality (AR) in Healthcare Market Trends and Forecast Analysis: Revenue Share Insights by 2031
Augmented Reality (AR) in Healthcare Market Trends and Forecast Analysis: Revenu …
The global augmented reality (AR) in healthcare market is anticipated to grow at a CAGR of 24.8% during the forecast period. The innovative product launches by key market players to meet the crucial medical demands is a key factor driving the growth of the global AR in healthcare market. For instance, in July 2022, Enovis has produced and launched a wearable AR device, ARVIS for orthopedic surgeries. The device is
Hairbrush Market Revenue Trends and Competitive Insights: Forecast to 2031
Hairbrush Market Revenue Trends and Competitive Insights: Forecast to 2031
The global hairbrush market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2024-2031). The growth of the market is attributed to increased awareness of social media and influencer marketing. Nowadays social media plays a significant role in influencing consumer preferences and purchasing decisions. Hair care influencers and beauty bloggers often recommend and promote different types of hair brushes, that can drive consumer interest and
Stationary Fuel Cell Market Dynamics: Growth Opportunities and Share Analysis by 2031
Stationary Fuel Cell Market Dynamics: Growth Opportunities and Share Analysis by …
The global stationary fuel cell market is anticipated to grow at a considerable CAGR of 13.1% during the forecast period. Surging investments from the private and public sectors focusing on establishing the hydrogen infrastructure along, with the growth in efficient power generation and transmission solutions support the growth of the market. Moreover, numerous government funding programs in line with the growing deployment of small and large-scale stationary fuel cells will
Cyber Security Insurance Market Forecast and Regional Analysis: Growth Factors by 2031
Cyber Security Insurance Market Forecast and Regional Analysis: Growth Factors b …
The global cyber security insurance market is anticipated to grow at a considerable CAGR of 19.2% during the forecast period (2024-2031). The cyber security insurance is a policy with an insurance carrier to mitigate risk exposure by offsetting costs involved with damages and recovery after a cyber-related security breach or similar event. The increase in frequency and severity of cyber-attacks has led to more organizations considering investments in cyber insurance.

All 5 Releases


More Releases for Orexin

Orexin Receptors (Hypocretin Receptor) Antagonist Market Is Likely to Tremendous …
Coherent Market Insights published a research report on Orexin Receptors (Hypocretin Receptor) Antagonist Market, focused on the market growth rate from 2022 to 2028. The report discusses growth patterns, growth drivers, futures institutions, opportunities, challenges, and profiles of major market players, segments, and regional analysis of the Orexin Receptors (Hypocretin Receptor) Antagonist market using what methodology and research form. In this report, market dynamics are related to the drivers, constraints, opportunities,
Orexin Receptors (Hypocretin Receptor) Antagonist Market [2022-2028] Booming Wor …
The Orexin Receptors (Hypocretin Receptor) Antagonist Market Report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this Orexin Receptors (Hypocretin Receptor) Antagonist Market report is to supply an in-depth view and strategic analysis of the parent industry. The report examines each segment also as their respective sub-segments present within the market in an all-inclusive
Orexin Receptor Market Top Leading Players with Strategies and Forecast 2027
The global orexin receptor market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Orexins are also known as hypocretins. They are two neuropeptides secreted from orexin-containing neurons, mainly in the lateral hypothalamus (LH). They play a vital regulatory role in many physiological processes such as feeding behavior, sleep-wake rhythm, reward and addiction and energy balance. The major factor driving the growth of the market is
Orexin Receptors (Hypocretin Receptor) Antagonist Market Is Booming Worldwide 20 …
𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 released a new market study on 2022-2028 Orexin Receptors (Hypocretin Receptor) Antagonist Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The global research report delivers an in-depth watch on leading competitors with strategic analysis, small and macro business trends and eventualities, valuation analysis and a holistic summary within the forecast amount. Its knowledge and in-depth
Orexin Receptors (Hypocretin Receptor) Antagonist Market to See Booming Growth 2 …
Coherent Market Insights has announced new analysis on Orexin Receptors (Hypocretin Receptor) Antagonist Market Status 2022-2028 which has been prepared based on an in-depth market analysis with inputs from industry experts and top vendors in the business. The report covers the market landscape and its development prospects over the coming years. The report also contains a discussion of the key vendors operating in this market. The market analysis report speaks about
Orexin Receptors (Hypocretin Receptor) Antagonist Market Outlook 2026: Sanofi, P …
Orexin (hypocretin) is a neuropeptide produced by the lateral hypothalamus which regulates the wakefulness, appetite, arousal and other habits. Orexin receptor antagonist is the new class of drugs are used in the treatment of insomnia. Suvorexant, is a dual orexin receptor antagonist drug that blocks both pathways of OX1R and OX2R. It develops sleep by the binding inhibition of orexin A and B, neuropeptides that promote wakefulness. Approximately 70,000